Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices 34045 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–846] 

Bulk Manufacturer of Controlled 

Substances Application: Chemic 

Laboratories 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Chemic Laboratories, has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 27, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 27, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on April 30, 2021, Chemic 

Laboratories, 480 Neponset Street, 

Building 7, Canton, Massachusetts 

02021–1971, applied to be registered as 

a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Psilocybin ..................... 7437 I 

Psilocyn ........................ 7438 I 

The company plans to manufacture 

small quantities of the listed controlled 

substances for research and 

development in preclinical studies for 

sale to its customers. No other activities 

for these drug codes are authorized for 

this registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–13671 Filed 6–25–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–859] 

Importer of Controlled Substances 

Application: AMRI Rensselaer, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: AMRI Rensselaer, Inc. has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 28, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 28, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on May 20, 2021, AMRI 

Rensselaer, Inc., 33 Riverside Avenue, 

Rensselaer, New York 12144, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Poppy Straw Concentrate ...... 9670 II 

The company plans to import the 

listed controlled substance to 

manufacture a bulk controlled substance 

for distribution to its customers. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–13672 Filed 6–25–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1121–0292] 

Agency Information Collection 

Activities; Proposed Collection 

Comments Requested; Extension of 

Currently Approved Collection: Survey 

of Sexual Victimization (SSV) 

AGENCY: Bureau of Justice Statistics, 

Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Justice 

(DOJ), Office of Justice Programs, 

Bureau of Justice Statistics, will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

was previously published in the Federal 

Register, allowing a 60-day comment 

period. Following publication of the 60- 

day notice, the Bureau of Justice 

Statistics received no substantive 

comments. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until July 28, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 


khammond on DSKJM1Z7X2PROD with NOTICES

I I